BCM
OCAT

BlueCrest Capital Management’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History

BlueCrest Capital Management’s Portfolio OCAT Stock Details OCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-25,400
Closed -$156K – 1022
2015
Q1 		$156K Buy
+25,400
New +$163K 0.01% 574

Other funds holding OCAT

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlueCrest Capital Management's OCAT Position: Q2 2015 in Review

BlueCrest Capital Management sold out of OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) in Q2 2015, closing a stake of 25,400 shares — an estimated $156K sold.

BlueCrest Capital Management first reported a position in OCAT in Q1 2015 and held it in 1 quarter. The position peaked at $156K in Q1 2015. 60 funds tracked by Wall St. Rank hold OCAT as of Q2 2015.

  • BlueCrest Capital Management reported no remaining OCATA THERAPEUTICS, INC. COMMON STOCK position as of Q2 2015 after selling out during the quarter.
  • BlueCrest Capital Management sold 25,400 OCATA THERAPEUTICS, INC. COMMON STOCK shares in Q2 2015, an estimated $156K.
  • BlueCrest Capital Management first reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK in Q1 2015 and held it in 1 quarter.
  • BlueCrest Capital Management's OCATA THERAPEUTICS, INC. COMMON STOCK position peaked at $156K in Q1 2015.
  • 60 funds tracked by Wall St. Rank held OCATA THERAPEUTICS, INC. COMMON STOCK as of Q2 2015.

Based on BlueCrest Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.